• Latest Posts

‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Biogen acquiring Reata Pharmaceuticals for $7.3B

FDA approves Alzheimer’s treatment

Biogen ALS drug gets FDA ok

ADVERTISEMENT

9 neuroscience biotech companies you should know about

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

In Depth 3 Oct 2017

How Close Are We to Curing ALS? A Review of Biotech’s Efforts

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

ADVERTISEMENT